Stay updated on SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.

Latest updates to the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page
- CheckyesterdayChange DetectedThe page’s interface/update label changes from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a backend/front-end version bump for ClinicalTrials.gov without altering the study record content.SummaryDifference0.0%

- Check8 days agoChange DetectedA new revision v3.5.2 was posted on 2026-04-13, adding a Study Status section and referencing 124 changes; the previous revision v3.5.0 was posted on 2026-03-24.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a new Study Status section (revision 123) on 2026-03-23 to show the current recruitment/status, with a prior item removed on 2026-02-02.SummaryDifference0.1%

- Check36 days agoChange DetectedThe history now includes revision v3.5.0 and removes v3.4.3. This is a page revision update and does not modify the study data or main content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.3 has been added to the page history, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check72 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed from the list.SummaryDifference0.0%

Stay in the know with updates to SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.